Ovid Therapeutics CEO gifts 1.15M shares to family trusts for estate planning

Ovid Therapeutics Inc.

CEO Jeremy Levin gifted 1,146,500 shares of Ovid common stock to family trusts for his two daughters.
After gift, Dr. Levin holds 3,598,467 shares of outstanding common stock.
Transfers made for no consideration as part of year-end estate tax planning.
Form 4 filed with SEC on December 6, 2023 reporting the gifts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.